Ocular adverse events of systemic inhibitors of the epidermal growth factor receptor: report of 5 cases

Ophthalmology
Alejandro Saint-JeanNicolas Molina-Prat

Abstract

To describe the ocular effects associated with the administration of the systemic epidermal growth factor receptor (EGFR) inhibitors panitumumab and erlotinib. Retrospective, noncomparative interventional case series. Ten eyes of 5 patients in treatment with systemic EGFR inhibitors, 4 patients with erlotinib for end-stage lung carcinoma, and 1 patient with panitumumab for end-stage colorectal cancer. Data collected from charts included gender, age at presentation, systemic disease, and clinical presentation in each eye. Demographics on presentation and clinical findings. Multiple epithelial defects were observed in all 10 eyes, corneal melting and thinning were observed in 3 eyes of 2 patients, 2 eyes of 1 patient presented with lower lid ectropion, and 2 eyes of 2 patients presented with corneal perforation, both requiring a penetrating keratoplasty. Severe ocular side effects, including corneal perforation, may be associated with the use of the EGFR inhibitors panitumumab and erlotinib.

References

May 1, 1990·Archives of Ophthalmology·H M LeibowitzA Kupferman
Apr 1, 1993·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·H WatanabeK Ohshiden
Apr 20, 2001·Experimental Eye Research·Y NakamuraS Kinoshita
Jun 19, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L CastilloG Milano
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Román Pérez-SolerPhilip Bonomi
Oct 13, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-C SoriaJ-P Armand
Oct 14, 2005·Expert Review of Anticancer Therapy·Ewan R Brown, Frances A Shepherd
Jan 24, 2007·Ophthalmic Plastic and Reconstructive Surgery·Amanda B Methvin, Roberta E Gausas
Jan 24, 2007·Ophthalmic Plastic and Reconstructive Surgery·Katherine Lane, Scott M Goldstein
Jul 20, 2007·Phytotherapy Research : PTR·Koneni V SashidharaNaibedya Chattopadhyay
Nov 22, 2007·Ophthalmic Plastic and Reconstructive Surgery·Benjamin J Frankfort, Daniel C Garibaldi
Mar 20, 2008·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C G FörsterF E Kruse
Aug 22, 2008·Orbit·Rebecca PapadopoulosAlexandre Bachariou
Nov 14, 2008·Journal of Cellular Physiology·Marlon R Schneider, Eckhard Wolf
Jun 11, 2009·Cornea·Keegan S JohnsonDavis S Chu
Dec 4, 2009·Cutaneous and Ocular Toxicology·Muhammad Wasif Saif, Joseph Gnanaraj
Jan 7, 2010·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Rajen U DesaiNorman A Saffra
Jan 26, 2010·Expert Opinion on Investigational Drugs·Muhammad W Saif
Jul 16, 2010·Ophthalmology·F W Fraunfelder, F T Fraunfelder
Nov 26, 2010·Cutaneous and Ocular Toxicology·E Bonafonte MárquezPedro A Martínez-Carpio
Dec 17, 2010·Nature Reviews. Cancer·C René LeemansRuud H Brakenhoff
Jan 21, 2011·Recent Patents on Anti-cancer Drug Discovery·Shahzad RazaMadhumati Kalavar
Feb 22, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Giannis Mountzios, Kostas N Syrigos
Mar 11, 2011·The New England Journal of Medicine·Vince D CataldoAlfonso Quintás-Cardama
Apr 6, 2011·Gastrointestinal Cancer Research : GCR·Majed El ZouhairiMichael J Pishvaian
Apr 14, 2011·Acta Clinica Belgica·M Van den EyndeJ P Machiels
Apr 21, 2011·Current Oncology·N Mittmann, S J Seung
Jun 10, 2011·Current Oncology·L G T MorrisM D Delacure
Jun 22, 2011·OncoTargets and Therapy·Marc S Ballas, Abraham Chachoua
Nov 30, 2011·Cutaneous and Ocular Toxicology·Frederick T Fraunfelder, Frederick W Fraunfelder
May 23, 2012·International Journal of Dermatology·Laura J PaulRazelle Kurzrock

❮ Previous
Next ❯

Citations

Feb 15, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Devron R ShahRashmi R Shah
Sep 5, 2015·Cutaneous and Ocular Toxicology·Hui-Chuan Kau, Chieh-Chih Tsai
Jan 28, 2014·Pharmacoepidemiology and Drug Safety·Ana MiguelAltamiro Costa Pereira
May 7, 2013·Ophthalmology·Vanissa W S ChowStanley C C Chi
Jan 17, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R Shah, Devron R Shah
Jun 10, 2017·Current Opinion in Ophthalmology·Richard C Allen
Nov 7, 2019·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Chang-Chi WengPei-Yu Lin
Apr 9, 2020·Expert Opinion on Drug Safety·Jia-Ying ZhouYi-Long Wu
Dec 30, 2017·International Journal of Molecular Medicine·Qi-Chen YangYi Shao
Jan 18, 2018·Orbit·Stacy Scofield-KaplanBryan J Winn
Apr 1, 2021·Drugs·Blake H FortesLauren A Dalvin
Mar 18, 2021·The Oncologist·Nagham Al-ZubidiAung Naing

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.